426 studies found for:    United States, Vermont | University of Vermont
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Condition: Huntington's Disease
Intervention:
2 Active, not recruiting A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma
Interventions: Drug: TH-302 in Combination with Doxorubicin;   Drug: Doxorubicin
3 Active, not recruiting Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
Conditions: Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: sunitinib malate;   Other: placebo;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis
4 Active, not recruiting Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: adult human mesenchymal stem cells;   Drug: Placebo
5 Completed
Has Results
Long-term Effect of Lanthanum Carbonate on Bone
Condition: Hyperphosphatemia
Intervention:
6 Active, not recruiting Pioglitazone in Early Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Pioglitazone;   Drug: placebo
7 Completed Minocycline to Treat Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: minocycline
8 Recruiting A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis
Condition: Idiopathic Gastroparesis
Intervention: Drug: Olanzapine
9 Unknown  The Effect of Estrogen and Progesterone Levels on Knee and Ankle Joint Laxity
Condition: Healthy
Intervention:
10 Completed A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction
Condition: Opioid Dependency
Interventions: Drug: Probuphine (buprenorphine implant);   Drug: placebo implant;   Drug: Buprenorphine
11 Completed Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation
Conditions: Pregnancy;   Unexplained Infertility
Interventions: Drug: Letrozole (aromatase inhibitor);   Drug: Clomiphene Citrate;   Drug: Follicle Stimulating Hormone (gonadotropin)
12 Terminated Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride
Condition: Chronic Kidney Failure
Interventions: Drug: Fermagate;   Drug: Sevelamer hydrochloride
13 Active, not recruiting
Has Results
Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
Conditions: Contiguous Stage II Grade 1 Follicular Lymphoma;   Contiguous Stage II Grade 2 Follicular Lymphoma;   Contiguous Stage II Grade 3 Follicular Lymphoma;   Noncontiguous Stage II Grade 1 Follicular Lymphoma;   Noncontiguous Stage II Grade 2 Follicular Lymphoma;   Noncontiguous Stage II Grade 3 Follicular Lymphoma;   Stage III Grade 1 Follicular Lymphoma;   Stage III Grade 2 Follicular Lymphoma;   Stage III Grade 3 Follicular Lymphoma;   Stage IV Grade 1 Follicular Lymphoma;   Stage IV Grade 2 Follicular Lymphoma;   Stage IV Grade 3 Follicular Lymphoma
Interventions: Biological: rituximab;   Drug: lenalidomide
14 Unknown  Bone Turnover in Type 2 Diabetes Patients
Condition: Type 2 Diabetes
Interventions: Drug: Sitagliptin;   Drug: Placebo
15 Recruiting Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
Conditions: Disseminated Neuroblastoma;   Localized Resectable Neuroblastoma;   Localized Unresectable Neuroblastoma;   Regional Neuroblastoma;   Stage 4S Neuroblastoma
Interventions: Drug: isotretinoin;   Biological: sargramostim;   Biological: dinutuximab;   Biological: aldesleukin;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment;   Other: pharmacological study
16 Unknown  Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection
Condition: Campylobacter Infections
Intervention: Biological: Campylobacter jejuni strain CG8421
17 Recruiting Increasing Cardiac Rehabilitation Participation Among Medicaid Enrollees
Condition: Coronary Artery Disease
Intervention: Behavioral: Financial incentives
18 Active, not recruiting Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
Conditions: Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma;   Stage III Childhood Hodgkin Lymphoma;   Stage IV Childhood Hodgkin Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: doxorubicin hydrochloride;   Drug: liposomal vincristine sulfate;   Drug: vinorelbine tartrate;   Drug: cyclophosphamide;   Drug: etoposide phosphate;   Drug: prednisone;   Biological: filgrastim;   Drug: ifosfamide
19 Active, not recruiting Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
Conditions: Disseminated Neuroblastoma;   Localized Resectable Neuroblastoma;   Localized Unresectable Neuroblastoma;   Regional Neuroblastoma;   Stage 4S Neuroblastoma
Interventions: Biological: therapeutic immune globulin;   Other: clinical observation;   Drug: cyclophosphamide;   Drug: prednisone;   Procedure: magnetic resonance imaging;   Other: laboratory biomarker analysis;   Drug: Corticotropin-Releasing Hormone
20 Active, not recruiting Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: B-cell Adult Acute Lymphoblastic Leukemia;   B-cell Childhood Acute Lymphoblastic Leukemia;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Lymphoblastic Lymphoma;   T-cell Adult Acute Lymphoblastic Leukemia;   T-cell Childhood Acute Lymphoblastic Leukemia
Interventions: Drug: asparaginase;   Drug: doxorubicin hydrochloride;   Drug: therapeutic hydrocortisone;   Drug: liposomal vincristine sulfate;   Drug: cytarabine;   Drug: prednisone;   Drug: bortezomib;   Drug: pegaspargase;   Drug: methotrexate;   Drug: etoposide phosphate;   Drug: cyclophosphamide;   Biological: filgrastim;   Drug: leucovorin calcium;   Other: laboratory biomarker analysis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years